Alexander's, Inc.
ALX
Updated: 24/09/2026, 07:44:31
Alexander’s, Inc. is a real estate investment trust (REIT) engaged in leasing, managing, developing and redeveloping properties. Alexander’s activities are conducted through its manager, Vornado Realty Trust. Alexander’s has five properties in the greater New York City metropolitan area consisting of: 731 Lexington Avenue office and retail (including Bloomberg, L.P.'s world headquarters), the Rego Center complex in Rego Park, Queens, including the Rego Park I & II retail properties and The Alexander apartment tower, and a retail property located in Flushing, NY. Alexander's, Inc. was incorporated in 1928 and is based in Paramus, United States.
No summaries found.
- Share price
- $247.87
- Market cap
- $1.27B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Steven Roth
- Employees
- 103
- IPO date
- 21/02/1973
- Beta
- 0.75
- Last dividend
- $0.00
- Day range
- $245.85 – $248.84
- 52-week range
- $201.28 – $289.43
- 1-day performance
- -0.21%
- 1-year performance
- 23.15%
- Current drawdown (1Y)
- -14.36%
- CIK
- 0000003499
- CUSIP
- 014752109
- ISIN
- US0147521092
- Created
- 07/12/2025, 02:02:54
- Last update
- 24/09/2026, 07:44:31
Track Alexander's, Inc. with an AI analyst
See which prediction-market events move ALX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
The Most Hated High Yields On Wall Street
Forbes • STOCK • 17/05/2026, 13:00:10
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewsWire • STOCK • 08/05/2026, 10:00:00
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
GlobeNewsWire • STOCK • 29/04/2026, 13:30:00
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
GlobeNewsWire • STOCK • 17/04/2026, 18:05:00
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
GlobeNewsWire • STOCK • 27/02/2026, 09:00:00
Alexander's (ALX) Upgraded to Buy: Here's What You Should Know
Zacks Investment Research • STOCK • 26/02/2026, 14:00:44
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
GlobeNewsWire • STOCK • 19/02/2026, 09:33:00
Alexander's (ALX) Misses Q4 FFO and Revenue Estimates
Zacks Investment Research • STOCK • 09/02/2026, 12:20:20
Alexander's Announces Fourth Quarter Financial Results
GlobeNewsWire • STOCK • 09/02/2026, 10:08:00
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
GlobeNewsWire • STOCK • 04/02/2026, 14:38:00